GlassScriptPhysician profile
Peter J Wong
NPI 1154493070
$6,210.24
in general payments reported to CMS, 2019-2025
15 companies · $733 in 2025
The $733 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $805 · 2020: $809 · 2021: $848 · 2022: $1,171 · 2023: $1,331 · 2024: $514 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,578.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,559.53 | 2021-2025 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $1,246.79 | 2019-2025 | Sapien 3 Ultra Resilia |
| Medtronic Vascular, INC. | $962.53 | 2019-2020 | |
| Abbott Laboratories | $379.52 | 2023-2025 | Aveir, Jot Dx |
| Amgen INC. | $283.23 | 2022-2025 | Krystexxa, Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $202.73 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $128.52 | 2022 | |
| Cardiovascular Systems INC. | $126.93 | 2020-2022 | |
| Horizon Therapeutics Plc | $120.86 | 2023 | Krystexxa |
| Heartflow, INC. | $60.86 | 2024 | |
| Inari Medical, INC. | $41.13 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Acist Medical Systems, INC. | $28.50 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $28.12 | 2019-2020 | |
| Shockwave Medical, INC | $22.85 | 2022 | |
| Abbvie INC. | $18.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.